Each of the 4 potassium binders that were compared in a study had advantages and disadvantages, investigators reported. The 4 main potassium binders all have short-term efficacy in lowering serum ...

Both potassium binders effectively lowered serum potassium levels in patients on hemodialysis meeting hyperkalemia definitions, compared with no treatment, investigators reported. Both patiromer and ...

Gut bacteria, microbiome. Bacteria inside the large intestine, concept, representation. 3D illustration. Gut bacteria, microbiome. Bacteria inside the large intestine, concept, representation. 3D ...

As explained by the National Kidney Foundation, the goal of management of chronic hyperkalemia -- i.e., high levels of potassium in the blood -- is to prevent the development or recurrence of the ...

CHICAGO -- Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients with heart failure with reduced ejection fraction (HFrEF) during ...

For decades, resin therapy has been used to manage hyperkalemia, especially in patients with advanced and end-stage kidney disease. The most common resin, sodium polystyrene sulfonate (SPS), has ...

This article does not describe studies showing one potassium binder is superior to the others; it seems all three lower potassium levels better than placebos. While the use of one potassium binder was ...

The US Food and Drug Administration (FDA) has asked the maker of sodium polystyrene sulfonate (Kayexalate), Concordia Pharmaceuticals, to conduct studies of the drug's potential to interact with other ...